| Application no. and date | 18814445.5 (espacenet) (Federated) (European Patent Register), 20180606 | | Patent/reg. no. and date | DK/EP 3635108, 20251203 | | Publication date | 20200415 | | Priority no. and date | US 201762516432 P, 20170607, US 201762531626 P, 20170712 | | EP pub. no. and date |
EP 3635108 20200415 | | Effective date | | | Applicant/owner | Spark Therapeutics, Inc., 3737 Market Street
Suite 1300
Philadelphia, Pennsylvania 19104, US | | Applicant ref. no. | | | Inventor | QU, Guang, 22 Beaver Dam Drive
Sicklerville
New Jersey 08081, US,
LU, Lin, 439 Robin Hill Road
Wayne
Pennsylvania 19087, US,
WRIGHT, John Fraser, 68 River Birch Circle
Princeton
New Jersey 08540, US,
JOSUE-ALMQVIST, Jesusa, 1520 Ashton Road
Havertown
Pennsylvania 19083, US | | Representative | | | Opponent | | | IPC Class | A61K 47/60 (2017.01) , C12N 15/09 (2006.01) , C12N 15/63 (2006.01) , C12N 15/86 (2006.01) , C12N 15/87 (2006.01) | | Title | ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION | | Int. application no. | US2018036344 | | Int. publication no. | WO2018226887 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
